-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Divozilimab in Systemic Sclerosis (Scleroderma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Divozilimab in Systemic Sclerosis (Scleroderma) Drug Details: Divozilimab (Ivlizi) is a monoclonal antibody. It is...
-
Product Insights
NewSleep Apnea Diagnostic Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Sleep Apnea Diagnostic Systems Pipeline Market Report Overview Sleep Apnea Diagnostic Systems include polysomnography systems (PSG systems) used for the screening of sleep apnea. These include systems and devices used for the diagnosis of sleep apnea. One PSG system includes amplifiers, a hard disk, a monitor, a recorder, a laser printer, electrodes, cables, stands, stimulators, chest and abdomen respiration belts, and sensors. Fixed and portable polysomnography systems are tracked under this category. The Sleep Apnea Diagnostic Systems pipeline market report...
-
Company Insights
Marsh – Tech Innovator Profile
This report provides insight into Marsh, including an overview of the company, coverage of its business model and operations, and biographies of its senior management. Marsh (a subsidiary of Marsh & McLennan Companies) is an insurance broking and risk management company. It serves both individual and commercial clients with data-enabled risk solutions and advisory services.
-
Thematic Analysis
State of the Biopharmaceutical Industry in 2024 – Thematic Intelligence
Accessing in-depth insights from the ‘State of the Biopharmaceutical Industry’ report will help you in: Examining the current attitudes of business leaders toward the emerging trends impacting the biopharmaceutical industry in the next 12 months. Benchmarking the impact of major themes on the biopharmaceutical industry in 2024, including emerging technologies, regulatory trends, macroeconomic trends, and industry trends. Identifying the most impactful anticipated regulatory approvals and drug launches in the industry in 2024, learning about top-selling drugs (2023 vs 2024), and obtaining...
-
Product Insights
Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ablation Equipment Pipeline Market Report Overview An Ablation Equipment is a device used to surgically remove a body tissue. The Ablation Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories ·       The US ·       Europe...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dapansutrile in Gouty Arthritis (Gout)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dapansutrile in Gouty Arthritis (Gout) Drug Details: Dapansutrile (OLT-1177) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Divozilimab in Neuromyelitis Optica (Devic’s Syndrome)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Divozilimab in Neuromyelitis Optica (Devic’s Syndrome)Drug Details:Divozilimab (Ivlizi) is a monoclonal antibody. It is formulated as...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adalimumab Biosimilar in Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adalimumab Biosimilar in Uveitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adalimumab biosimilar in Uveitis Drug Details: Adalimumab (Yuflyma) is a human...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adalimumab Biosimilar in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adalimumab Biosimilar in Psoriasis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adalimumab biosimilar in Psoriasis Drug Details: Adalimumab (Yuflyma) is a human...